Id |
Subject |
Object |
Predicate |
Lexical cue |
T183 |
0-2 |
Sentence |
denotes |
4. |
T184 |
3-93 |
Sentence |
denotes |
Relationship between C4-O- and C9-O-Acetyl SA Preferences of CoVs in Host Cell Recognition |
T185 |
95-99 |
Sentence |
denotes |
4.1. |
T186 |
100-127 |
Sentence |
denotes |
General O-Acetylation of SA |
T187 |
128-317 |
Sentence |
denotes |
SAs have various derivatives of more than 50 chemically different structures formed from the basic N-acetylneuraminic acid (Neu5Ac) on the main ring of pyranose and the glycerol side chain. |
T188 |
318-426 |
Sentence |
denotes |
SA are modified by acetyl-, lactyl-, methyl- and sulfo-groups individually or in multiple combinations [28]. |
T189 |
427-483 |
Sentence |
denotes |
Multiple enzymes are involved in the modifications [29]. |
T190 |
484-622 |
Sentence |
denotes |
Historically, the first discovered SA was crystallized by Gunner Blix via a hot mild acid extraction of bovine submaxillary mucin in 1936. |
T191 |
623-657 |
Sentence |
denotes |
It consisted of two acetyl groups. |
T192 |
658-723 |
Sentence |
denotes |
Among these, only one acetyl group was attached to nitrogen [30]. |
T193 |
724-876 |
Sentence |
denotes |
Blix isolated a 9-O-acetyl SA of the common SA N-acetylneuraminic acid (Neu5Ac), chemically described as 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac2). |
T194 |
877-952 |
Sentence |
denotes |
Neu5,9Ac2, Neu5Ac and Neu5Gc are naturally occurring SA species in mammals. |
T195 |
953-992 |
Sentence |
denotes |
A common modification is O-acetylation. |
T196 |
993-1046 |
Sentence |
denotes |
In fact, O-acetylation of SAs is common in organisms. |
T197 |
1047-1216 |
Sentence |
denotes |
The O-acetyl modification occurs in single positions of C-4, C-7, C-8 and C-9 of SA as well as in combined C-positions to yield Neu4,5Ac2, Neu5,9Ac2 and Neu5,7,9Ac3 SAs. |
T198 |
1217-1292 |
Sentence |
denotes |
Neu5Ac9NAc is a chemical and biologic mimic of Neu5,9Ac2 in the SA-glycans. |
T199 |
1293-1423 |
Sentence |
denotes |
The C-7 and/or C-9 O-acetylations are catalyzed by the SA O-acetyltransferase enzyme, Cas1 domain containing 1 (CasD1) (Figure 6). |
T200 |
1424-1529 |
Sentence |
denotes |
CasD1 catalyzes the addition of acetyl groups to the SA C-7 at the late Golgi apparatus compartment [31]. |
T201 |
1530-1674 |
Sentence |
denotes |
Thereafter, an enzyme termed “migrase” transfers the additional acetyl-group from C-7 to C-9, although this enzyme has not been identified [29]. |
T202 |
1675-1803 |
Sentence |
denotes |
CasD1 uses acetyl-coenzyme A as a donor substrate and CMP-Neu5Ac as an acceptor substrate, but with weak activity on CMP-Neu5Gc. |
T203 |
1804-1958 |
Sentence |
denotes |
Biologically, the SA O-acetylation event confers merits to hosts such as protection from pathogenic invasion and maintenance of systemic self-homeostasis. |
T204 |
1959-2121 |
Sentence |
denotes |
The O-acetylation event of SAs protects the SA-containing glycans from neuraminidase (NA)/sialidase action, because O-acetyl-groups inhibit microbial NA activity. |
T205 |
2122-2221 |
Sentence |
denotes |
The chemical structure of the O-acetyl group is quite unstable and susceptible to esterase enzymes. |
T206 |
2222-2355 |
Sentence |
denotes |
Sialic acid cleavage of the di-acetylated Neu5,7,9Ac3 by bacterial NAs decreases two-fold, when compared to mono-O-acetylated Neu5Ac. |
T207 |
2356-2465 |
Sentence |
denotes |
The O-acetylated glycan modification invites interaction with viruses, antibodies and mammalian lectins [32]. |
T208 |
2466-2551 |
Sentence |
denotes |
Therefore, the SA O-acetylation modification confers specific functions to organisms. |
T209 |
2553-2557 |
Sentence |
denotes |
4.2. |
T210 |
2558-2642 |
Sentence |
denotes |
Evolutionary Acquisition of C4-O-Acetyl and C9-O-Acetyl SA Recognition by HE Enzymes |
T211 |
2644-2650 |
Sentence |
denotes |
4.2.1. |
T212 |
2651-2675 |
Sentence |
denotes |
C4-O-Acetyl Modification |
T213 |
2676-2790 |
Sentence |
denotes |
For example, in the horse, C4-O-acetyl modification of Neu5Ac (SA) occupies more than 50% of the total SA content. |
T214 |
2791-2865 |
Sentence |
denotes |
The C4-O-acetylated Neu5Ac, Neu4,5Ac2, inhibits the influenza A2 virus HA. |
T215 |
2866-3003 |
Sentence |
denotes |
De-acetylation reagents such as NaOH or NaIO4 treatment completely hemagglutinate Neu4,5Ac2 by elimination of the C4-O-acetyl group [33]. |
T216 |
3004-3141 |
Sentence |
denotes |
The C4-O-acetyl Neu5Ac species are found in various sources such as equine erythrocyte GM3, starfish A. rubens and fish [34,35,36,37,38]. |
T217 |
3142-3227 |
Sentence |
denotes |
C4-O-acetylated Neu5Ac facilitates the initial attachment of viruses to target cells. |
T218 |
3228-3397 |
Sentence |
denotes |
Like the influenza C virus, infectious salmon anemia virus (ISAV), a member of the Orthomyxoviridae family, contains HE and HEF proteins to mediate virus entry and exit. |
T219 |
3398-3551 |
Sentence |
denotes |
C4-O-Ac Neu5Ac is the major receptor determinant of ISAV in receptor binding and destruction [38], while the influenza C virus recognizes C9-O-Ac Neu5Ac. |
T220 |
3552-3743 |
Sentence |
denotes |
The acetylesterase RDE of ISAV cleaves C4-O-Ac via 4-SA-O-acetylesterase with a short turnover time, whereas C9-O-Ac Neu5Ac is cleaved by 9-SA-O-acetylesterase with a long turnover time [34]. |
T221 |
3744-3883 |
Sentence |
denotes |
The position of SA O-acetylation is linked to functions including substrate differentiation of enzymes such as NAs and esterase by C4 O-Ac. |
T222 |
3884-4013 |
Sentence |
denotes |
Previous development of O-Ac site-selective NA inhibitors were based on the conceptual consideration of different O-Ac positions. |
T223 |
4014-4122 |
Sentence |
denotes |
The O-Ac of SAs is site-specific, as C4 of Neu5Ac is considered to be a potential position for modification. |
T224 |
4123-4231 |
Sentence |
denotes |
Historically, inhibitors of influenza A and B viruses-sialidases were designed by Von-Itzstein in 1993 [39]. |
T225 |
4232-4341 |
Sentence |
denotes |
The Ac group-based C4 substitution interacts with amino acid Glu-119 present in the active site of sialidase. |
T226 |
4342-4511 |
Sentence |
denotes |
Guanidine-attached C4 of C2–C3 unsaturated SA (Neu5Ac2en) inhibits activity of sialidases isolated from influenza A virus (Singapore/1/57) and B virus (Victoria/102/85). |
T227 |
4512-4646 |
Sentence |
denotes |
The same scenario was applied for sialidase inhibition of the human parainfluenza virus type 3, which has HN and fusion proteins [40]. |
T228 |
4647-4725 |
Sentence |
denotes |
The C4 of Neu5Ac2en was substituted by alkyl groups such as the O-ethyl group. |
T229 |
4726-4815 |
Sentence |
denotes |
For example, Zanamivir has a substitution with a 4-guanidino group with an IC50 of 25 μM. |
T230 |
4816-4889 |
Sentence |
denotes |
Thus, sialidase inhibition is important for C4 modification of Neu5Ac2en. |
T231 |
4890-5033 |
Sentence |
denotes |
Later, oseltamivir with the tradename Tamiflu (Basel, Switzerland) and zanamivir with the tradename Relenza (London, UK) were established [41]. |
T232 |
5034-5107 |
Sentence |
denotes |
These drugs exhibit some adverse side effects that restrict clinical use. |
T233 |
5109-5115 |
Sentence |
denotes |
4.2.2. |
T234 |
5116-5143 |
Sentence |
denotes |
SA C9-O-Acetyl Modification |
T235 |
5144-5322 |
Sentence |
denotes |
The SA 9-O-acetylation in hosts allows hosts to evade influenza A virus hemagglutinin (HA) recognition and some lectins of factor H (FH), CD22/Siglec-2 and sialoadhesin/Siglec-1. |
T236 |
5323-5452 |
Sentence |
denotes |
Instead, the influenza C virus HA recognizes the hosts. β-elimination and permethylation eliminate the 9-O-acetyl group from SAs. |
T237 |
5453-5695 |
Sentence |
denotes |
Chemical modification of the C-9 position of Neu5,9Ac2 generates a 9-N-acetyl analog, 9-acetamido-9-deoxy-N-acetylneuraminic acid (Neu5Ac9NAc), a mimic of Neu5,9Ac2 with influenza C virus-binding capacity, which is not cleaved by the HE [42]. |
T238 |
5696-5762 |
Sentence |
denotes |
SA O-acetylesterase regulates the presence of 7,9-O-Ac and 9-O-Ac. |
T239 |
5763-5849 |
Sentence |
denotes |
SA O-acetylation and deacetylation are involved in development, cancer and immunology. |
T240 |
5850-5916 |
Sentence |
denotes |
SA O-acetylation alters host lectin bindings such as siglecs [29]. |
T241 |
5917-5981 |
Sentence |
denotes |
The presence of 9-O-Ac can also reduce the activity of NAs [43]. |
T242 |
5982-6041 |
Sentence |
denotes |
SA modifications regulate pathogen binding or pathogen NAs. |
T243 |
6042-6100 |
Sentence |
denotes |
Influenza A/B/C/D viruses use SA as their entry receptors. |
T244 |
6101-6236 |
Sentence |
denotes |
Influenza A and B subtypes bind to SAs via HA and NA to allow endocytosis of the virus and fusion of the viral envelope with endosomes. |
T245 |
6237-6347 |
Sentence |
denotes |
In contrast, influenza C and D subtypes bear only one coated glycoprotein, termed the HE fusion protein (HEF). |
T246 |
6348-6378 |
Sentence |
denotes |
The HEF acts as the HA and NA. |
T247 |
6379-6566 |
Sentence |
denotes |
HEF recognizes 9-O-acetyl SA for entry into cells, while the esterase domain removes 9-O-acetyl-groups and liberates the virus from mucus and mis-assembled virus aggregates after budding. |
T248 |
6567-6662 |
Sentence |
denotes |
The 9-O-Ac on cells prevents the NA activity and HA binding of the influenza A type virus [44]. |